BWC to end coverage of OxyContin



The Bureau of Workers’ Compensation (BWC) recently announced that it will stop covering payments for OxyContin, as well as generic sustained-release oxycodone tablets, to workers who sustain work-related injuries on or after June 1, 2019. This new rule was recommended by the BWC’s Pharmacy and Therapeutics Committee, which advises the BWC on actions to address the opioid epidemic and its negative impact on the state’s workforce.

The BWC will replace OxyContin with Xtampza ER, a drug that is considered as effective as OxyContin but less likely to lead to abuse. Injured workers already authorized for OxyContin will have until December 31, 2019, to discontinue their use or switch to a different product on the BWC formulary.

Media Contact

Subscribe to Receive Updates
Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.